Paradiso Beatrice, Bianchini Enzo, Cifelli Pierangelo, Cavazzini Luigi, Lanza Giovanni
Department of Morphology, Surgery and Experimental Medicine, Section of Anatomic Pathology, University of Ferrara and S. Anna University Hospital Via Aldo Moro, 8, 44124 Cona, Ferrara, Italy ; Department of Medical Sciences, Section of Pharmacology and Neuroscience Center, University of Ferrara, Via Aldo Moro, 8, 44124 Cona, Italy ; National Institute of Neuroscience, Italy.
Department of Morphology, Surgery and Experimental Medicine, Section of Anatomic Pathology, University of Ferrara and S. Anna University Hospital Via Aldo Moro, 8, 44124 Cona, Ferrara, Italy.
Case Rep Med. 2014;2014:453874. doi: 10.1155/2014/453874. Epub 2014 May 15.
We report a new case of p63/cytokeratin 7 (CK7) positive syringocystadenocarcinoma papilliferum (SCACP), on the shoulder of an 88-year-old man, with superficial dermal infiltration and squamoid differentiation. We describe the 24th case of SCACP, the malignant counterpart of syringocystadenoma papilliferum (SCAP). At the present, we do not know whether SCACP arises from eccrine or apocrine glands because of the contrasting opinions in the literature. Only few histochemical and ultrastructural studies have previously advised that SCACP could arise from pluripotent stem cells. Through our case, we wish to suggest the stem cell-like properties of the syringocystadenocarcinoma papilliferum. This rare neoplasm shows two different patterns of stem cell marker expression in the glandular and squamous components, respectively. For the double phenotype of SCACP, we propose it like an intriguing model to study histogenesis and stem cell properties for more wide-ranging epithelial tumors.
我们报告了一例发生于一名88岁男性肩部的p63/细胞角蛋白7(CK7)阳性的乳头状汗管囊腺瘤(SCACP)新病例,该病例存在真皮浅层浸润和鳞状分化。我们描述了第24例SCACP,它是乳头状汗管囊腺瘤(SCAP)的恶性对应物。目前,由于文献中的观点存在差异,我们尚不清楚SCACP是起源于小汗腺还是大汗腺。此前仅有少数组织化学和超微结构研究表明SCACP可能起源于多能干细胞。通过我们的病例,我们希望提示乳头状汗管囊腺癌具有类似干细胞的特性。这种罕见的肿瘤在腺性和鳞状成分中分别呈现出两种不同的干细胞标志物表达模式。对于SCACP的双重表型,我们将其作为一个有趣的模型,用于更广泛地研究上皮性肿瘤的组织发生和干细胞特性。